BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32778002)

  • 21. A service evaluation of the use of faecal immunochemical tests in symptomatic patients aged under 50 years presenting to primary care.
    Tibbs RE; Benton SC
    Ann Clin Biochem; 2024 Jan; 61(1):48-54. PubMed ID: 37414413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
    Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
    Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
    Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J
    BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.
    Clark GR; Godfrey T; Purdie C; Strachan J; Carey FA; Fraser CG; Steele RJ
    J Med Screen; 2024 Mar; 31(1):21-27. PubMed ID: 37469171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham.
    Chapman C; Thomas C; Morling J; Tangri A; Oliver S; Simpson JA; Humes DJ; Banerjea A
    Colorectal Dis; 2020 Jun; 22(6):679-688. PubMed ID: 31876975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.
    Selby K; Levine EH; Doan C; Gies A; Brenner H; Quesenberry C; Lee JK; Corley DA
    Gastroenterology; 2019 Dec; 157(6):1494-1505. PubMed ID: 31472152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
    Pin-Vieito N; Iglesias MJ; Remedios D; Rodríguez-Alonso L; Rodriguez-Moranta F; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Martínez-Bauer E; Campo R; Bujanda L; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Cubiella J; On Behalf Of The Colonpredict Study Investigators
    World J Gastroenterol; 2020 Jan; 26(1):70-85. PubMed ID: 31933515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
    Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
    Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
    McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
    Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
    Saw KS; Liu C; Xu W; Varghese C; Parry S; Bissett I
    Br J Surg; 2022 Feb; 109(2):182-190. PubMed ID: 34907419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal immunochemical testing reduces demand and improves yield of Leicester's 2-week pathway for change in bowel habit.
    Khasawneh F; Osborne T; Danaher P; Barnes D; Chapman CJ; Stephenson JA; Singh B
    Colorectal Dis; 2023 Apr; 25(4):640-646. PubMed ID: 36478367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
    Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N
    Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
    Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
    J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies.
    Li SJ; Sharples LD; Benton SC; Blyuss O; Mathews C; Sasieni P; Duffy SW
    J Med Screen; 2021 Sep; 28(3):277-285. PubMed ID: 33342370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
    Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
    Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal Immunochemical Testing in Patients With Low-Risk Symptoms of Colorectal Cancer: A Diagnostic Accuracy Study.
    Ball AJ; Aziz I; Parker S; Sargur RB; Aldis J; Kurien M
    J Natl Compr Canc Netw; 2022 Sep; 20(9):989-996.e1. PubMed ID: 36075395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An observational study of replicate faecal immunochemical tests in the urgently referred symptomatic cohort.
    Farkas NG; O'Brien J; Whyte M; Jourdan I; Rockall T; Benton SC
    Ann Clin Biochem; 2023 Sep; 60(5):313-319. PubMed ID: 36864586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.